Acute Opioid Receptor Blockade Restores Vascular Endothelial Growth Factor and Astrocyte Response in db/db Mouse Brain Following Hypoxia-Ischemic Injury
Journal of Neuroscience Research April 2026 Acute Opioid Receptor Blockade Restores Vascular Endothelial Growth Factor and Astrocyte Response in db/db Mouse Brain Following Hypoxia-Ischemic Injury Rashmi Kumari, Elizabeth A Proctor & Patricia McLaughlin Abstract Diabetes plays an important role in the pathogenesis of ischemic stroke and brain recovery. We have reported the neuroprotective effect of […]
Will Low Dose Naltrexone (LDN) Be Helpful for Diabetes?
Is low-dose naltrexone effective in chronic pain management? (Abstract)
Is low-dose naltrexone effective in chronic pain management? J Fam Pract September 2023 https://pubmed.ncbi.nlm.nih.gov/37729143/ YES. Low-dose naltrexone is as effective as amitriptyline in the treatment of painful diabetic neuropathy and has a superior safety profile (strength of recommendation [SOR], B; single randomized controlled trial [RCT]). Low-dose naltrexone significantly reduced pain by 32% in inflammatory conditions […]
Pamela Smith, MD, MPH, MS – Insulin Resistance & Diabetes – 2022 Conference (LDN; low dose naltrexone)
Pamela Smith, MD, MPH, MS – Insulin Resistance & Diabetes – 2022 Conference (LDN; low dose naltrexone)
LDN therapy a new hope for people suffering from chronic pain? (in Polish) (News)
LDN therapy a new hope for people suffering from chronic pain? MedExpress Team 17 August 2023 https://www.medexpress.pl/blogosfera/terapia-ldn-nowa-nadzieja-dla-osob-cierpiacych-na-przewlekly-bol/ Chronic pain is one of the most common physical issues impacting up to 25% of the population at various times in their lives. Given that chronic pain can be difficult to treat with conventional methods, doctors and scientists […]
The Utilization of Low Dose Naltrexone for Chronic Pain (Abstract)
The Utilization of Low Dose Naltrexone for Chronic Pain CNS Drugs 28 July 2023 https://pubmed.ncbi.nlm.nih.gov/37505425/ Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with others, were developed with the intention of reversing the effects of opioid abuse or toxicity. Evidence has also shown that naltrexone […]
JanOnes Innovative Approach to Addressing Chronic Pain Filing International Patent Application for Low Dose Naltrexone (News)
JanOnes Innovative Approach to Addressing Chronic Pain Filing International Patent Application for Low Dose Naltrexone Best Stocks 28 June 2023 https://beststocks.com/janones-innovative-approach-to-addressing-chr/ On June 28, 2023, JanOne made a significant move by filing an international patent application for innovative methods involving the utilization of low dose naltrexone to effectively address chronic pain. This groundbreaking development showcases […]
Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions… (Abstract)
Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions – A Scoping Review Pain Med 11 June 2023 https://pubmed.ncbi.nlm.nih.gov/37302106/ Background: At low doses, naltrexone (LDN) has been shown to modulate inflammation through the interruption of microglial cell activation within the central nervous system. One of the most likely contributors to centralized pain is changes in […]
Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series (Abstract)
Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series J Pain Res 14 June 2023 https://pubmed.ncbi.nlm.nih.gov/37337611/ Purpose: Low-dose naltrexone (LDN) has increased in popularity as a non-opioid medication that may decrease chronic pain symptoms. LDN is most commonly used to treat fibromyalgia, complex regional pain syndrome (CRPS), and painful diabetic neuropathy. […]
LDN może pomóc w regeneracji po udarze mózgu (in Polish) (News)
LDN may help with stroke recovery (in Polish) (News) Medexpress.pl 16 May 2023 https://www.medexpress.pl/blogosfera/ldn-moze-pomoc-w-regeneracji-po-udarze-mozgu/ LDN) increases the concentration of β-endorphin and supports the regeneration of neurons after hypoxia and ischemic stroke in mice with type 2 diabetes. Diabetes not only increases the incidence of ischemic stroke in all age groups in humans, but also worsens […]